Abstract: As GenAI technologies, particularly Large Language Models (LLMs), continue to revolutionize programming and data science, it is increasingly vital for educators to adapt computer science ...

The series includes 35 Zoom and in-person lectures for a fee of $25 a person or $40 a couple, according to a community announcement. The spring semester runs March 9-April 16, with lectures Mondays ...

The series includes 35 Zoom and in-person lectures for a fee of $25 a person or $40 a couple, according to a community announcement. The spring semester runs March 9-April 16, with lectures Mondays ...

Jan 16 (Reuters) - The executive board of the International Monetary Fund completed the latest review of Ethiopia's current financial program on Friday, the fund said in a statement, a move that will ...

Addis Ababa, December 20, 2025 (ENA) —A PhD Mobility Program, which offers PhDs to more than 1,000 Ethiopian scholars in India or in joint supervision with Indian mentors in the coming five years, was ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Ethiopia's state-owned telecom operator, Ethio Telecom, launched a new three-year strategy on Tuesday, August 26, to transform the company into a diversified technology provider. Dubbed "Next Horizon: ...

Addis Ababa, August 20, 2025 (ENA) – Ethiopia’s Urban Development Safety Net Program is helping citizens move from dependency to economic productivity, Ministry of Urban and Infrastructure announced.

WASHINGTON, August 1, 2025 — The World Bank Board of Executive Directors has approved the Accelerating Sustainable and Clean Energy Access Transformation (ASCENT) in Ethiopia Program-for-Results ...

The measure will require geolocation data to show that beans aren’t linked to deforestation. Farmers say they need more time to prepare. By Shola Lawal Farmers in Africa that produce some of the world ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...